<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To define the neoplastic risk in the remaining colon after proctectomy for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> in patients with <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">hereditary nonpolyposis colorectal cancer</z:e> (HNPCC) </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: The extent of surgery for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> in HNPCC is controversial </plain></SENT>
<SENT sid="2" pm="."><plain>In determining which operation to perform, surgeons and patients must consider <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in the remaining colon as well as functional consequences of removing the entire colorectum </plain></SENT>
<SENT sid="3" pm="."><plain>The natural history of colon <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in this situation is understudied and is not well-defined </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A single-institution hereditary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> database was queried for patients meeting Amsterdam criteria and with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Patient demographics, surgical management, and follow-up were recorded </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Fifty HNPCC patients with a primary diagnosis of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> treated by proctectcomy were included </plain></SENT>
<SENT sid="7" pm="."><plain>Detailed follow-up colonoscopy data were available for 33 patients </plain></SENT>
<SENT sid="8" pm="."><plain>Forty-eight high-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath> developed in 13 patients (39.4%) </plain></SENT>
<SENT sid="9" pm="."><plain>Five patients (15.2%) developed metachronous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> at a median of 6 years (range 3.5-16) after proctectomy, including 3 at advanced stage </plain></SENT>
<SENT sid="10" pm="."><plain>One of these patients developed a high-risk <z:mpath ids='MPATH_270'>adenoma</z:mpath> before <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Mean interval between the last <z:mpath ids='MPATH_458'>normal</z:mpath> colonoscopy and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> discovery was 42 months (range 23.8-62.1) with one developing within 2 years </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, 17 of 33 patients (51.5%) developed high-risk <z:mpath ids='MPATH_270'>adenoma</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> after proctectomy </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Surgeons and patients need to be aware of substantial risk for metachronous <z:hpo ids='HP_0002664'>neoplasia</z:hpo> after proctectomy </plain></SENT>
<SENT sid="14" pm="."><plain>Selection of operation should be individualized, but total proctocolectomy and ileoanal pouch should be strongly considered </plain></SENT>
<SENT sid="15" pm="."><plain>If patients undergo proctectomy alone, close surveillance is mandatory </plain></SENT>
</text></document>